Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Patient and Stakeholder Engagement 3 of the Hardest Obstacles We Face in Alzheimer’s Clinical Drug Trials By Sebastian Turek October 9, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 8: Finding Another Way By Scott Millard October 3, 2017 Patient and Stakeholder Engagement Why the time’s right for a Rare Disease Film Festival By Premier Research September 26, 2017 Clinical ResearchPhase 1 - Phase 4 The ABC’s of OA By Scott Millard September 26, 2017 Clinical ResearchPhase 1 - Phase 4 Fragile X: The Quest to Treat a Complex, Little-Understood Condition By Premier Research September 25, 2017 Clinical ResearchPhase 1 - Phase 4 The Placebo Problem, Part 7: Drug-Placebo Interactions By Scott Millard September 21, 2017 Previous 1 …38 39 40 41 42 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today